Viewing Study NCT06396663



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06396663
Status: RECRUITING
Last Update Posted: 2024-05-02
First Post: 2024-04-03

Brief Title: DE-eSCALation of Opioids Post-surgical dischargE
Sponsor: University of Kent
Organization: University of Kent

Study Overview

Official Title: The Role of the Clinical Pharmacist in Reducing Opioid Dependence at the Interface Between Hospital and Primary Care
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DESCALE
Brief Summary: The Descale Study aims to

1 Look at the prescribing trends of opioids and the scale of long-term use following surgery within East Kent United Kingdom
2 Carry out a feasibility study to

see if clinical pharmacists can support patients following surgery to manage their post-surgical pain safely and prevent long-term opioid use
calculate how much it costs the National Health Service NHS
see how the patients experienced the intervention

For Aim 1 historic records of patients who have had surgery and were discharged on opioids will be reviewed Data collected will include type and strength of pain-relieving medication prescribed type of surgery number of additional opioid prescriptions following discharge use of medical services eg General Practice appointments physiotherapy and patient demographics

For Aim 2 clinical pharmacists will carry out early high-risk medication safety reviews to ensure that patients have their pain managed safely Investigators will collect key data from patients receiving the clinical pharmacist intervention to see how it affected opioid use costs and healthcare use Patients who took part in the study will be invited to participate in an interview and will be asked what they know about opioids and the health risks and their experiences of the intervention
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None